Key Highlights
- Tim Scott to succeed Joe Panetta as Biocom California’s president and CEO.
- Scott has been active on Biocom’s board since 2010, serving as chair since 2022.
- Sabrina Martucci Johnson to succeed Scott as board chair.
- Scott’s leadership experience spans over 20 years in the biotech industry.
Source: Business Wire
Notable Quotes
- “Joe’s leadership and vision has transformed our industry, both in California and in Washington, D.C.” – Tim Scott, CEO at Biocom California
- “Tim’s career… gives him a nuanced perspective that will serve our members across all facets of the life science industry well.” – Joe Panetta, President and CEO at Biocom California
- “I am confident that Tim’s experience, drive and dedication will enable him to excel as our new leader.” – Sabrina Martucci Johnson, President and CEO at Daré Bioscience
SoHC's Take
Tim Scott’s appointment as Biocom California’s new president and CEO marks a significant transition for the organization. His extensive experience in biotech leadership and his deep commitment to the life science community position him as an ideal successor to Joe Panetta. Scott’s background in founding and leading multiple biotech companies, combined with his advocacy for workforce development and STEM education, will be invaluable as he navigates the future of Biocom California. Under his leadership, the organization is poised to continue its growth and strengthen its impact on the global life sciences industry.
